Gene · 5355
Papers1,588
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 1,588
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Oligomerization and Spatial Distribution of Kvβ1.1 and Kvβ2.1 Regulatory Subunits. | Front Physiol | 2022 | 35784882 | PubTator, text mining | PubMed |
| The Metacognitive and Neurocognitive Signatures of Test Methods in Academic Listening. | Front Psychol | 2022 | 35783744 | PubTator, text mining | PubMed |
| Relationships Between Biological Heavy Metals and Breast Cancer: A Systematic Review and Meta-Analysis. | Front Nutr | 2022 | 35782923 | PubTator, text mining | PubMed |
| Inhibition of Porcine Epidemic Diarrhea Virus by Cinchonine via Inducing Cellular Autophagy. | Front Cell Infect Microbiol | 2022 | 35774410 | PubTator, text mining | PubMed |
| Senescent cells limit p53 activity via multiple mechanisms to remain viable. | Nat Commun | 2022 | 35764649 | PubTator, text mining | PubMed |
| Coronaviral PLpro proteases and the immunomodulatory roles of conjugated versus free Interferon Stimulated Gene product-15 (ISG15). | Semin Cell Dev Biol | 2022 | 35764457 | PubTator, text mining | PubMed |
| Screening Host Antiviral Proteins under the Enhanced Immune Responses Induced by a Variant Strain of Porcine Epidemic Diarrhea Virus. | Microbiol Spectr | 2022 | 35762780 | PubTator, text mining | PubMed |
| Discovering Common miRNA Signatures Underlying Female-Specific Cancers via a Machine Learning Approach Driven by the Cancer Hallmark ERBB. | Biomedicines | 2022 | 35740327 | PubTator, text mining | PubMed |
| Hypoxia Selectively Increases a SMAD3 Signaling Axis to Promote Cancer Cell Invasion. | Cancers (Basel) | 2022 | 35681731 | PubTator, text mining | PubMed |
| Bioactive Compounds and Functional Properties of Herbal Preparations of Cystus creticus L. Collected From Rhodes Island. | Front Nutr | 2022 | 35677542 | PubTator, text mining | PubMed |
| Establishment of Organoids From Human Epithelioid Sarcoma With the Air-Liquid Interface Organoid Cultures. | Front Oncol | 2022 | 35677170 | PubTator, text mining | PubMed |
| The Evolutionary Dance between Innate Host Antiviral Pathways and SARS-CoV-2. | Pathogens | 2022 | 35631059 | PubTator, text mining | PubMed |
| Self-amplifying loop of NF-κB and periostin initiated by PIEZO1 accelerates mechano-induced senescence of nucleus pulposus cells and intervertebral disc degeneration. | Mol Ther | 2022 | 35619555 | PubTator, text mining | PubMed |
| Cryo-sensitive aggregation triggers NLRP3 inflammasome assembly in cryopyrin-associated periodic syndrome. | Elife | 2022 | 35616535 | PubTator, text mining | PubMed |
| Natural Compound ZINC12899676 Reduces Porcine Epidemic Diarrhea Virus Replication by Inhibiting the Viral NTPase Activity. | Front Pharmacol | 2022 | 35600889 | PubTator, text mining | PubMed |
| Mutations of the nACh Receptor M4 Helix Reveal Different Phenotypes in Different Expression Systems: Could Lipids be Responsible? | Front Physiol | 2022 | 35600303 | PubTator, text mining | PubMed |
| Pilot study evaluating everolimus molecular mechanisms in tuberous sclerosis complex and focal cortical dysplasia. | PLoS One | 2022 | 35587487 | PubTator, text mining | PubMed |
| MEOX2 Regulates the Growth and Survival of Glioblastoma Stem Cells by Modulating Genes of the Glycolytic Pathway and Response to Hypoxia. | Cancers (Basel) | 2022 | 35565433 | PubTator, text mining | PubMed |
| Exosomal miRNAs as a Promising Source of Biomarkers in Colorectal Cancer Progression. | Int J Mol Sci | 2022 | 35563246 | PubTator, text mining | PubMed |
| Systematic analysis of IL-6 as a predictive biomarker and desensitizer of immunotherapy responses in patients with non-small cell lung cancer. | BMC Med | 2022 | 35550592 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5355/papers?page=13